Cash · 2011–2025
Alnylam Pharmaceuticals cash
$1.7B+71.5% · FY2025
Alnylam Pharmaceuticals (ALNY) reported $1.7B in cash for fiscal 2025, +71.5% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.7B | +71.5% | Open → |
| FY20242024-12-31 | $966M | +18.9% | Open → |
| FY20232023-12-31 | $813M | −6.2% | Open → |
| FY20222022-12-31 | $866M | +5.7% | Open → |
| FY20212021-12-31 | $820M | +65.1% | Open → |
| FY20202020-12-31 | $497M | −9.2% | Open → |
| FY20192019-12-31 | $547M | +30.2% | Open → |
| FY20182018-12-31 | $420M | −34.9% | Open → |
| FY20172017-12-31 | $645M | +233.3% | Open → |
| FY20162016-12-31 | $194M | +7.0% | Open → |
| FY20152015-12-31 | $181M | +140.6% | Open → |
| FY20142014-12-31 | $75.2M | +41.4% | Open → |
| FY20132013-12-31 | $53.2M | +3.4% | Open → |
| FY20122012-12-31 | $51.4M | −26.8% | Open → |
| FY20112011-12-31 | $70.2M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +25.3%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Alnylam Pharmaceuticals cash |url=https://companiesranked.com/en/company/alnylam-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Alnylam Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/alnylam-pharmaceuticals/cash-on-handBibTeX
@misc{companiesranked-en-company-alnylam-pharmaceuticals-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Alnylam Pharmaceuticals cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/alnylam-pharmaceuticals/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001178670-26-000062 · July 30, 2026
{{cite web |title=Alnylam Pharmaceuticals cash — 10-Q (0001178670-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1178670/000117867026000062/alny-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-30}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.